Offer for Calyx Group plc

Calyx Group PLC 25 May 2007 FOR IMMEDIATE RELEASE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION 25 May 2007 Recommended Acquisition for cash of Calyx Group plc ('Calyx') by Stornoway Limited ('Stornoway') Summary • The boards of directors of Stornoway and Calyx announce that they have reached agreement on the terms of a recommended acquisition by Stornoway of the entire issued and to be issued share capital of Calyx. It is intended that the Acquisition will be implemented by way of a scheme of arrangement under Section 201 of the Companies Act. • Under the terms of the Acquisition, each holder of Cancellation Shares will receive 101 pence in cash per Cancellation Share representing a premium of approximately 23.9 per cent. to the Closing Price of 81.5 pence per Calyx Share on 12 March 2007, being the last Business Day prior to the commencement of the Offer Period. • The Acquisition values Calyx's existing issued share capital at approximately £70.2 million. • Stornoway has been incorporated for the purpose of implementing the Acquisition. On the Effective Date, Stornoway will ultimately be owned by the Alchemy Investment Plan and the Management Team. • Maurice Healy, the Chairman and Chief Executive of Calyx, who owns 19,329,799 Calyx Shares (representing 27.80 per cent. of the existing issued share capital of the Company), has agreed to exchange 13,530,693 of those shares for an investment in the Stornoway Group and the balance of his Calyx Shares for cash pursuant to the Scheme. • The Stornoway Directors believe that the Acquisition will provide Calyx with the opportunity to expand its current business, both organically and via acquisitions, in the absence of the financial, managerial and regulatory burden of being a publicly quoted company. • The Independent Directors of Calyx, who have been so advised by Davy Corporate Finance, consider the terms of the Acquisition to be fair and reasonable. In providing its advice, Davy Corporate Finance has taken into account the commercial assessments of the Independent Directors. Accordingly, the Independent Directors intend to recommend unanimously that Calyx Shareholders vote in favour of the Acquisition and the Scheme, as they have irrevocably undertaken to do in respect of their own beneficial holdings, amounting to, in aggregate, 20,000 Calyx Shares, representing 0.03 per cent. of the existing issued share capital of the Company. • Stornoway has received irrevocable undertakings or letters of intent to vote in favour of the Scheme from certain institutional shareholders in respect of, in aggregate, 16,579,124 Calyx Shares, representing approximately 23.85 per cent. of the existing issued share capital of Calyx. Further details relating to the irrevocable undertakings are set out in paragraph 5 of the announcement. • The Scheme will be put to Calyx Shareholders for approval at the Court Meetings and at the EGM. A resolution to approve the Management Arrangements between the Stornoway Group and the Management Team, on which only the Independent Shareholders will be entitled to vote, will be considered at the EGM. Such meetings, and the posting of the Scheme Document to Calyx Shareholders, are expected to take place as soon as reasonably practicable. • The making of the Acquisition and the Scheme are subject to the conditions and further terms set out in Appendix 1. Deloitte Corporate Finance is acting as financial adviser to Stornoway. Davy Corporate Finance is acting as financial adviser and corporate broker to Calyx. Commenting on the Acquisition on behalf of the Management Team, Maurice Healy, Chairman of Calyx and a Director of Stornoway, said: 'I am pleased we have come to an agreement to acquire the shares in Calyx and that we have a full recommendation from the Independent Directors. The acquisition price of 101 pence represents a healthy premium to the Calyx share price prior to the Company entering an offer period and provides Shareholders with the opportunity to realise their holdings in full, for cash and free of dealing costs. The Management Team is looking forward to taking on the challenges that lie ahead as a private company. ' Commenting on the Acquisition on behalf of the Independent Directors, Gary Kennedy, Director of Calyx, said: 'The Independent Directors have given this matter careful consideration. We have concluded that the Acquisition, which allows shareholders to realise their holdings in full for cash, is in the best interests of Calyx Shareholders and is fair and reasonable. We will be recommending Calyx Shareholders vote in favour of the Acquisition and the Scheme.' Enquiries: Deloitte Corporate Finance +44 (0) 20 7936 3000 Financial Adviser to Stornoway Limited Jonathan Hinton David Smith Buchanan Communications +44 (0) 20 7466 5000 Public Relations adviser to Stornoway Limited Tim Thompson James Strong Calyx Group plc +353 (0) 1 883 5555 Gary Kennedy Davy Corporate Finance +353 (0) 1 679 6363 Financial Adviser to Calyx Group plc Ronan Godfrey John Frain Murray Consultants +353 (0) 1 498 0300 Public Relations adviser to Calyx Group plc Ed Micheau This summary should be read in conjunction with the full text of the following announcement and the Appendices, which are part of the announcement. Appendix 2 contains source notes relating to certain information contained in this summary and the following announcement. Certain terms used in this summary and the following announcement are defined in Appendix 3. The directors of Stornoway, Stornoway I, Clayfox Timid and Clayfox Gilttop, acting in their capacity as such, the directors of Alchemy Partners (Guernsey), and the Management Team (together the 'Responsible Parties'), accept responsibility for the information contained in this announcement relating to Stornoway, Stornoway I, Clayfox Timid, Clayfox Gilttop, the directors of Alchemy Partners (Guernsey) and the Management Team and members of their immediate families, related trusts and persons connected with them. To the best of the knowledge and belief of the Responsible Parties (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. The Calyx Directors accept responsibility for all the information contained in this announcement, other than information relating to Stornoway, Stornoway I, Clayfox Timid, Clayfox Gilttop, the Management Team or the directors of Alchemy Partners (Guernsey) and members of their immediate families, related trusts and persons connected with them, and the recommendation of the Acquisition and the Scheme by the Independent Directors and associated opinions. To the best of the knowledge and belief of the Calyx Directors (who have taken all reasonable care to ensure that such is the case), the information in this announcement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. The Independent Directors accept responsibility for their recommendation of the Acquisition and the Scheme and associated opinions contained in this announcement. To the best of the knowledge and belief of the Independent Directors (who have taken all reasonable care to ensure that such is the case), the information for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. This announcement is not intended to and does not constitute an offer to sell or subscribe for or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise. Any response in relation to the Acquisition should be made only on the basis of the information in the Scheme Document or any document by which the Acquisition and Scheme are made. Calyx and Stornoway urge Calyx Shareholders to read the Scheme Document when it becomes available because it will contain important information relating to the Acquisition. Davy Corporate Finance, which is authorised in Ireland by the Financial Regulator under the Investment Intermediaries Act 1995, is acting exclusively for Calyx and no-one else in connection with the Acquisition and will not be responsible to anyone other than Calyx for providing the protections afforded to clients of Davy Corporate Finance or for providing advice in relation to the Acquisition. Deloitte Corporate Finance is acting exclusively for Stornoway and no-one else in connection with the Acquisition and will not regard any other person as its client nor be responsible to anyone other than Stornoway for providing the protections afforded to clients of Deloitte Corporate Finance nor for providing advice in relation to the Acquisition, or any matter referred to in this announcement. Deloitte Corporate Finance is a division of Deloitte & Touche LLP, which is authorised and regulated by the Financial Services Authority in respect of regulated activities. The distribution of this announcement in or into certain jurisdictions may be restricted by the laws of those jurisdictions. Accordingly, copies of this announcement and all other documents relating to the Acquisition are not being, and must not be, mailed or otherwise forwarded, distributed or sent in, into or from any Restricted Jurisdiction. Persons receiving such documents (including, without limitation, nominees, trustees and custodians) should observe these restrictions. Failure to do so may constitute a violation of the securities laws of any such jurisdiction. This announcement, including information included or incorporated by reference in this announcement, may contain 'forward-looking statements' concerning the Acquisition, Calyx, Stornoway, Stornoway I, Clayfox Timid and Clayfox Gilttop. Generally, the words 'will', 'may', 'should', 'could', 'would', 'can', 'continue', 'opportunity', 'believes', 'expects', 'intends', 'anticipates', 'estimates' or similar expressions identify forward-looking statements. The forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond the companies' abilities to control or estimate precisely, such as future market conditions and the behaviours of other market participants, and therefore undue reliance should not be placed on such statements. Neither Calyx, Stornoway, Stornoway I, Clayfox Timid nor Clayfox Gilttop assume any obligation in respect of, or intend to update these forward-looking statements, except as required pursuant to applicable law. This announcement is made pursuant to Rule 2.5 of the Takeover Rules. Any person who is a holder of one per cent. or more of the Calyx Shares may have disclosure obligations under Rule 8.3 of the Takeover Rules, effective from the date of the commencement of the offer period in respect of the Acquisition. FOR IMMEDIATE RELEASE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION 25 May 2007 Recommended Acquisition for cash of Calyx Group plc ('Calyx') by Stornoway Limited ('Stornoway') 1. Introduction The Board of Stornoway and the Independent Directors of Calyx announce that they have reached agreement on the terms of a recommended acquisition by Stornoway of the entire issued and to be issued share capital of Calyx. Stornoway is a company established for the purpose of the Acquisition. On the Effective Date, Stornoway will ultimately be owned by the Alchemy Investment Plan and certain members of the current Calyx management team, namely Maurice Healy (Chairman and Chief Executive), Peter Jenkins (Chief Financial Officer), Gerard Coakley (Managing Director, Ireland), Andrew Mills (Managing Director, UK) and Jack Cunnane (Business Improvement Director). It is intended that the Acquisition will be implemented by way of a scheme of arrangement under Section 201 of the Companies Act. In view of the involvement of Maurice Healy, Peter Jenkins and Gerard Coakley in the Acquisition, and the resulting conflicts of interest, a committee of the Calyx Board, comprising the Independent Directors, has been formed and Davy Corporate Finance has been appointed to advise them in considering the terms of the Acquisition on behalf of Calyx Shareholders. By virtue of another conflict of interest, Judith O'Brien, a non-executive director, is not considered to be independent for the purposes of Rule 3 of the Takeover Rules. The Independent Directors of Calyx, who have been so advised by Davy Corporate Finance, consider the terms of the Acquisition to be fair and reasonable. In providing its advice, Davy Corporate Finance has taken into account the commercial assessments of the Independent Directors. Accordingly, the Independent Directors intend to recommend unanimously that Calyx Shareholders vote in favour of the Acquisition and the Scheme and the resolutions at the Court Meetings and EGM, as they have irrevocably undertaken to do in respect of their own beneficial holdings, amounting to, in aggregate, 20,000 Calyx Shares, representing 0.03 per cent. of the existing issued share capital of the Company. The making of the Acquisition and the Scheme are subject to the conditions and further terms set out in Appendix 1, which will also be set out in the Scheme Document. Certain terms used in this announcement are defined in Appendix 3. 2. Summary of the Acquisition Under the terms of the Scheme, holders of Cancellation Shares will receive: for each Cancellation Share 101 pence in cash This represents a premium of approximately 23.9 per cent. to the Closing Price of 81.5 pence per Calyx Share on 12 March 2007, being the last Business Day prior to the commencement of the Offer Period. The Acquisition values the existing issued share capital of the Company at approximately £70.2 million. 3. Background to and reasons for recommending the Acquisition As part of an announcement made on 12 December 2006, Calyx issued a trading update that informed the market, inter alia, that it was confident that the Group would continue to grow substantially both into and throughout 2007, that there had been good trading performance from the Matrix Companies that were acquired in June 2006 and that the results for Calyx for the year ended 31 December 2006 would be marginally below current market expectations. From that date, the Calyx share price performance has been somewhat disappointing until the announcement on 13 March 2007 that the Independent Directors had received a preliminary approach from Maurice Healy and certain members of the Company's senior management team that may or may not lead to an offer for the Company. The Independent Directors have made concerted efforts, in these circumstances, to seek the best outcome for Calyx Shareholders. On behalf of the Independent Directors, Davy Corporate Finance has conducted a process of contacting other potential offerors for Calyx. No other proposals have been received by the Company as at the date of this announcement. It is still possible that a proposal may emerge, and Maurice Healy has irrevocably and unconditionally agreed with Calyx to accept any Competing Cash Offer (being, inter alia, a cash offer at least 10 per cent. higher than 101 pence per Calyx Share) in respect of his Calyx Shares. The Independent Directors have concluded that although Calyx is well positioned to continue to expand both organically and by acquisition, the public capital markets may not be willing to support or finance such growth at this time and that the Calyx share price could be vulnerable in the absence of any offer being made. The Independent Directors believe that the Acquisition represents an attractive opportunity for Calyx Shareholders to realise a fair value for their Calyx Shares and therefore, having been so advised by Davy Corporate Finance, consider that the terms of the Acquisition are fair and reasonable and should therefore be put to Calyx Shareholders. Accordingly, the Independent Directors intend to recommend unanimously that Calyx Shareholders vote in favour of the Acquisition and the Scheme. In providing their advice to the Independent Directors, Davy Corporate Finance has taken into account the commercial assessments of the Independent Directors. 4. Background to and reasons for the Acquisition Calyx Shares were admitted to AIM on 17 March 2005. The purpose of the AIM admission was to raise the Company's profile, strengthen its balance sheet and provide a platform to enable it to position itself as a sector innovator, expand its product and technologies portfolio, and attract new clients. Since its flotation, Calyx has made a number of acquisitions, increasing the scale of its operations and growing its revenues from €38.4 million (for the year ended 31 December 2005) to €88.5 million (for the year ended 31 December 2006). The Stornoway Directors, including the founding director of Calyx, Maurice Healy, intend to pursue the Company's strategy of expansion via a mixture of organic growth and acquisitions but believe that it is more appropriate for Calyx to pursue these plans under private ownership. Completion of the Acquisition will release Calyx from the costs and obligations associated with a public listing and will allow Calyx to develop and grow its business for the benefit of its employees and clients, free from the short-term pressures that can adversely affect public companies. In particular, growth by way of acquisitions should be accelerated since the private equity partner will be able to make a rapid assessment of risk and therefore in theory provide the Company with access to significant levels of equity and debt capital. It is the intention of the Stornoway Directors to continue the business of Calyx broadly in the manner in which it currently exists and Stornoway will bring to bear the necessary expertise and financial resources to invest in the business in order to achieve its aims. The Acquisition represents an opportunity for Calyx Shareholders to realise their entire investment in Calyx for cash (without incurring dealing charges) at a price which represents a premium of approximately 23.9 per cent. to the Closing Price of 81.5 pence per Calyx Share on 12 March 2007, being the last Business Day prior to the commencement of the Offer Period. 5. Irrevocable undertakings Stornoway has received irrevocable undertakings to vote, or procure a vote, in favour of the Scheme in respect of a total of 23,086,596 Calyx Shares representing, in aggregate, 100.00 per cent. of the existing issued share capital of Calyx entitled to vote at the Court Meeting for Stornoway Class Shareholders. Stornoway has received irrevocable undertakings or letters of intent to vote, or procure a vote, in favour of the Scheme in respect of a total of 17,417,063 Calyx Shares representing, in aggregate, 37.50 per cent. of the existing issued share capital of Calyx entitled to vote at the Court Meeting for Calyx Shareholders other than Stornoway Class Shareholders. Stornoway has received irrevocable undertakings or letters of intent to vote, or procure a vote, in favour of the resolutions to be proposed at the EGM (other than the Rule 16 Resolution) in respect of a total of 40,503,659 Calyx Shares representing, in aggregate, 58.26 per cent. of the existing issued share capital of Calyx entitled to vote on those resolutions. Stornoway has received irrevocable undertakings or letters of intent to vote, or procure a vote, in favour of the Rule 16 Resolution at the EGM in respect of a total of 20,331,921 Calyx Shares representing, in aggregate, 41.20 per cent. of the existing issued share capital of Calyx held by the Independent Shareholders, who are the only Calyx Shareholders entitled to vote on the Rule 16 Resolution. Of these totals: Calyx Directors • Stornoway has received irrevocable undertakings to vote in favour of the Acquisition, the Scheme and the resolutions to be proposed at the EGM (including the Rule 16 Resolution) in respect of the entire beneficial holdings of all of the Independent Directors, amounting in aggregate to 20,000 Calyx Shares, representing 0.03 per cent. of the existing issued share capital of Calyx; and • Stornoway has received irrevocable undertakings to vote in favour of the Acquisition, the Scheme and the resolutions to be proposed at the EGM (including the Rule 16 Resolution) in respect of the entire beneficial holding of Judith O'Brien, amounting in aggregate to 817,939 Calyx Shares, representing 1.18 per cent. of the existing issued share capital of Calyx. Stornoway Class Shareholders • Stornoway has received irrevocable undertakings to vote in favour of the Acquisition and the Scheme at the Court Meeting at which they are entitled to vote, and in favour of the resolutions at the EGM on which they are entitled to vote (being all of the resolutions other than the Rule 16 Resolution), from the Management Team in respect of 20,171,738 Calyx Shares, representing 29.01 per cent. of the existing issued share capital of Calyx; and • Stornoway has received an irrevocable undertaking from Anglo Irish Bank Corporation plc to vote in favour of the Acquisition and the Scheme at the Court Meeting at which Anglo Irish Bank Corporation plc is entitled to vote, and in favour of the resolutions to be proposed at the EGM (including the Rule 16 Resolution), in respect of 2,914,858 Calyx Shares, representing 4.19 per cent. of the existing issued share capital of Calyx. The Stornoway Class Shareholders' Calyx Shares will not be permitted to be voted at the same Court Meeting at which other shareholders vote. The Management Team's Calyx Shares cannot be voted in favour of the Rule 16 Resolution at the EGM. Maurice Healy's irrevocable undertaking is subject to the terms of an undertaking he has given to Calyx that requires him to accept a Competing Cash Offer for Calyx in respect of his Calyx Shares. All of the irrevocable undertakings from the Calyx Directors and Stornoway Class Shareholders cease to be binding if Stornoway announces that it will not proceed to make the Acquisition, or the Scheme Document has not been posted by the twenty-eighth day after the date of this announcement (or such later date as Stornoway and Calyx may agree, with the consent of the Panel), or the Scheme does not become effective by 30 September 2007 (or such later date as Stornoway and Calyx may, with the consent of the Panel, agree and the High Court may allow), or the Scheme fails to become effective or is withdrawn. In addition, the irrevocable undertaking relating to Anglo Irish Bank plc will cease to be binding if a higher competing offer for Calyx is announced which is at least 10 per cent. higher than 101 pence per Calyx Share. Other Calyx Shareholders • Stornoway has received irrevocable undertakings to vote in favour of the Acquisition, the Scheme and the resolutions to be proposed at the EGM (including the Rule 16 Resolution) from Gartmore Investment Management Limited and Focus Investment Group in respect of their aggregate holdings of 15,404,124 Calyx Shares, representing 22.16 per cent. of the existing issued share capital of Calyx; and • Stornoway has received non-binding letters of intent to vote in favour of the Acquisition, the Scheme and the resolutions to be proposed at the EGM (including the Rule 16 Resolution) from the Universities Superannuation Scheme Limited in respect of 1,175,000 Calyx Shares, representing 1.69 per cent. of the existing issued share capital of Calyx. The irrevocable undertakings relating to Gartmore Investment Management Limited and Focus Investment Group cease to be binding if a higher competing offer for Calyx is announced which is at least 10 per cent. higher than 101 pence per Calyx Share or Stornoway announces that it will not proceed to make the Acquisition, or the Scheme Document has not been posted by the twenty-eighth day after the date of this announcement (or such later date as Stornoway and Calyx may agree, with the consent of the Panel), or the Scheme does not become effective by 30 September 2007 (or such later date as Stornoway and Calyx may, with the consent of the Panel, agree and the High Court may allow), or the Scheme fails to become effective or is withdrawn. 6. Information on the Calyx Group Calyx is one of the largest single-source providers of networked IT services in both the United Kingdom and Ireland. The Calyx Group provides its customers with fully managed, end-to-end solutions in data, voice, security, systems integration, applications, IP and carrier services. Headquartered in Dublin and with offices in Cork and Limerick in Ireland, and in Hook, Rainford, East Grinstead, Swindon and Richmond in the UK, Calyx employs approximately 500 people. In its unaudited preliminary results for the year ended 31 December 2006, the Calyx Group reported a 130 per cent. increase in turnover to €88.5 million from €38.4 million in the prior year and a 147 per cent. increase in group operating profit before goodwill amortisation and exceptional items to €9.4 million from €3.8 million in the prior year. As at 31 December 2006, the Calyx Group had consolidated net assets of €44.7 million (31 December 2005: €11.6 million). 7. Information on the Stornoway Group The Stornoway Group comprises Stornoway, Stornoway I (parent company of Stornoway), Clayfox Timid (parent company of Stornoway I) and Clayfox Gilttop (parent company of Clayfox Timid). All the companies in the Stornoway Group are recently incorporated companies established on behalf of the Management Team and Alchemy Partners (Guernsey) for the purpose of the Acquisition. The directors of Stornoway and Stornoway I are Maurice Healy, Martin Bolland and Gerard Coakley. The directors of Clayfox Timid and Clayfox Gilttop are Maurice Healy, Martin Bolland and Eric Lakin. Immediately following the Scheme becoming effective, the ordinary shares of Clayfox Gilttop will be held as to 20.0 per cent. by the Management Team (including Maurice Healy), a further 20.8 per cent. by Maurice Healy and 59.2 per cent. by the Alchemy Investment Plan. The Stornoway Group is being financed by £0.50 million of ordinary shares of Clayfox Gilttop to be subscribed by members of the Management Team, £0.52 million of ordinary shares of Clayfox Gilttop and £13.15 million of redeemable preference shares of Clayfox Timid to be subscribed by Maurice Healy pursuant to the Acquisition, £1.48 million of ordinary shares of Clayfox Gilttop and £37.39 million of loan notes in Clayfox Timid to be subscribed by the Alchemy Investment Plan and £65.23 million of senior debt and mezzanine finance to be provided by Anglo Irish Bank Corporation plc. To date, the Stornoway Group has neither traded nor engaged in any activities, other than those incidental to the incorporation of its constituent companies and the Acquisition. 8. Information relating to Alchemy Partners Alchemy Partners is a private equity advisory business established on 20 January 1997 which provides investment advice to Alchemy Partners (Guernsey). Alchemy Partners (Guernsey) is a registered Guernsey company which manages the Alchemy Investment Plan and carries out investments based on recommendations put forward by Alchemy Partners. Alchemy Partners (Guernsey) considers all recommendations and is solely responsible for the final decision to invest. Investors in the Alchemy Investment Plan include major banking institutions, pension funds and a number of private individuals. The Alchemy Investment Plan comprises a series of limited partnerships, in aggregate committed to investing £400 million per annum. In addition, it includes investments from the individual members of Alchemy Partners. The Alchemy Investment Plan has invested or committed to invest approximately £1.8 billion into other investments since 1997. No investments made on behalf of the Alchemy Investment Plan prior to the Acquisition have any known connections with Calyx and none of the directors of Alchemy Partners (Guernsey) have any prior interest in Calyx. 9. Financing the Acquisition The cash payable to Calyx Shareholders under the terms of the Scheme will be funded using a mixture of the equity subscriptions and debt facilities described in paragraph 7 above. Full implementation of the Acquisition and the Scheme would result in maximum cash payment of approximately £57.4 million being made to Calyx Shareholders and Calyx Optionholders. Deloitte Corporate Finance is satisfied that the necessary cash resources are available to Stornoway to enable it to satisfy in full the consideration payable to Calyx Shareholders under the terms of the Scheme and to Calyx Optionholders. 10. Management Arrangements and the Rule 16 Resolution It is intended that, in place of approximately £19.52 million in cash which would be realised by Maurice Healy pursuant to the terms of the Acquisition if all of his Calyx Shares were treated as Cancellation Shares, 13,530,693 of Mr Healy's Calyx Shares will be treated as Exchange Shares, 514,851 of which will be transferred to Clayfox Gilttop and 13,015,842 will be transferred to Clayfox Timid pursuant to the Scheme. As a result Mr Healy will receive 520,000 ordinary shares issued by Clayfox Gilttop and 13,146,000 redeemable preference shares issued by Clayfox Timid. The balance of Mr Healy's Calyx Shares, being 5,799,106 Calyx Shares, as well as all of the Calyx Shares held by other members of the Management Team will be treated as Cancellation Shares, save for any Calyx Shares issued pursuant to the exercise of Calyx Share Options after the date on which the Scheme is sanctioned by the High Court and prior to the Scheme Record Time which will be transferred to Stornoway in exchange for cash. In addition, the members of the Management Team (including Maurice Healy) have agreed to subscribe in cash for an aggregate of £0.50 million worth of ordinary shares in Clayfox Gilttop. A proportion of those ordinary shares to be issued to Maurice Healy will be transferred to senior executives of Calyx (other than the Management Team) at cost following completion of the Acquisition. All members of the Management Team intend to accept the offers to be made to Calyx Optionholders. Following the Scheme becoming effective the Management Team will have the following interests in the ordinary shares of Clayfox Gilttop: Percentage interest in Clayfox Gilttop Maurice Healy 30.8% Peter Jenkins 4.0% Ger Coakley 2.0% Andy Mills 2.0% Jack Cunnane 2.0% Total 40.8% The balance of the ordinary shares in Clayfox Gilttop will be held by the Alchemy Investment Plan, through its nominee, Alchemy Partners Nominees Limited. Upon the Scheme becoming effective, the Management Team will enter into new service agreements with Clayfox Gilttop, further details of which will be set out in the Scheme Document. In addition, under the Shareholders' Agreement, the Management Team is giving certain warranties to Alchemy Partners (Guernsey), and the parties thereto have certain rights and obligations in relation to transfers of shares, certain types of transactions and other matters customarily included in such agreements. Rule 16 of the Takeover Rules provides that, except with the consent of the Panel, an offeror or persons acting in concert with an offeror may not make arrangements with shareholders and may not deal, or enter into arrangements to deal, in shares of the offeree company or enter into arrangements which involve an acceptance of an offer either during an offer period or when an offer is reasonably in contemplation if there are favourable conditions attached which are not being extended to all shareholders. In relation to the agreements and other arrangements between the Stornoway Group and the Management Team as described above, the Panel has agreed, subject to the Rule 16 Resolution (formal notice of which will be set out in the Scheme Document) being passed on a poll of the Independent Shareholders at the EGM (or at any adjournment thereof), to permit the Management Arrangements to be implemented. The Management Team (to the extent that they are Calyx Shareholders) will not be entitled to vote on the Rule 16 Resolution. Davy Corporate Finance, which is acting as financial adviser to the Independent Directors, considers the terms of the Management Arrangements to be fair and reasonable as respects the interests of the Calyx Shareholders generally. 11. Management and employees The Board of Stornoway attaches great importance to the skills and experience of the management and employees of Calyx. The Board of Stornoway has provided assurances to the Independent Directors that, upon the Scheme becoming effective, the existing employment rights of all employees of Calyx, including pension rights, will be fully safeguarded. Stornoway has confirmed that the existing senior management team of Calyx will remain in place and that it has no current intention to change the day-to-day operations or locations of the business. Stornoway has also confirmed that it is committed to developing Calyx's business in Ireland and the United Kingdom, both organically and potentially through further acquisitions. The non-executive directors of Calyx have agreed to resign subject to, and with effect from, the Scheme becoming effective. The Independent Directors will not receive any compensation for loss of office other than payment in full of their fees for the notice periods under their respective terms of engagement. The Independent Directors, in their discussions with Stornoway, have no reason to believe that Stornoway's intentions would prejudice Calyx's employees and are comforted that Stornoway has no current plans to alter existing arrangements with employees or to change the locations of the Company's places of business. 12. Expenses reimbursement, exclusivity and implementation agreements Calyx has entered into the Expenses Reimbursement Agreement with Alchemy Partners (Guernsey) and the Management Team dated 9 May 2007, the terms of which have been approved by the Panel. Under the Expenses Reimbursement Agreement, Calyx has agreed to pay specific quantifiable third party costs and expenses incurred by Stornoway and/or by the Management Team and/or Alchemy Partners (Guernsey) in connection with the Acquisition in the circumstances outlined below. The liability of Calyx to pay these amounts is limited to a maximum amount equal to one per cent. of the Cash Consideration multiplied by the number of Calyx Shares in issue. The circumstances in which such payment will be made are: a) if the Independent Directors, or any of them, withdraw or adversely modify their recommendation of the Acquisition or recommend (or indicate or announce an intention to recommend) any third party transaction; or b) if, as a result of the act of an act of omission of Calyx, the Scheme Document is not posted to Calyx Shareholders within 28 days of the issue of this announcement or Calyx withdraws the Scheme or materially alters any terms of the Scheme or takes or omits any actions to prevent Calyx Shareholders voting at any meetings to approve the Scheme; or c) if the Acquisition lapses or (with the consent of Calyx) is withdrawn or does not become effective, and, prior to this occurring, a transaction is announced by a third party that subsequently becomes effective or unconditional. Davy Corporate Finance, the independent financial adviser to the Independent Directors, has confirmed in writing to the Panel that, in the opinion of the Independent Directors and Davy Corporate Finance, in the context of the Acquisition, the Expenses Reimbursement Agreement is in the best interests of Calyx Shareholders. Calyx has also entered into an exclusivity agreement with Alchemy Partners (Guernsey) and the Management Team dated 9 May 2007 whereby it has accepted certain restrictions on its ability to canvas, solicit or engage with other potential offerors. Calyx and Stornoway have entered into the Implementation Agreement dated 24 May 2007, which contains certain assurances in relation to the implementation of the Scheme. Further information regarding the Implementation Agreement will be set out in the Scheme Document. 13. Calyx Share Option Schemes As at the close of business on the Latest Practicable Date, the following Calyx Share Options had been granted to members of the Management Team and remained exercisable under the Calyx Share Option Schemes: Name Date of grant Price Exercisable From Exercisable Number of (pence) Until Calyx Share Options Maurice Healy 01/11/2006 90 01/11/2006 31/10/2009 500,000 Ger Coakley 17/03/2005 55 17/03/2005 16/03/2008 147,250 01/11/2006 90 01/11/2006 31/10/2009 102,750 Peter Jenkins 01/11/2006 90 01/11/2006 31/10/2009 300,000 Andy Mills 01/11/2006 90 01/11/2006 31/10/2009 200,000 Jack Cunnane 01/11/2006 90 01/11/2006 31/10/2009 100,000 Participants in the Calyx Share Option Schemes will be contacted regarding the effect of the Scheme on their rights under these schemes and appropriate proposals will be made to such participants in due course. 14. Disclosure of interests in Calyx As at the close of business on the Latest Practicable Date, the following members of the Management Team owned or controlled the following Calyx Shares: Calyx Shares Maurice Healy 19,329,799 Ger Coakley 817,939 Andy Mills 24,000 Save as disclosed in this paragraph 14 and the Calyx Share Options disclosed in paragraph 13, neither Stornoway, nor, so far as Stornoway is aware, any person acting in concert with Stornoway owns or controls any Calyx Shares or securities convertible or exchangeable into Calyx Shares or any rights to subscribe for or purchase, or holds any options in respect of, or derivatives referenced to, any such shares on behalf of Stornoway ('Calyx Securities') nor does any such person have any Arrangement in relation to Calyx Securities. 15. The Acquisition and the Scheme The Acquisition will be effected by means of a scheme of arrangement between Calyx and Calyx Shareholders (subject to the approval of the High Court) under Section 201 of the Companies Act. If the Scheme becomes effective, all the Cancellation Shares will be cancelled pursuant to Sections 72 and 74 of the Companies Act. Calyx will then issue new Calyx Shares to Stornoway in place of the Calyx Shares cancelled pursuant to the Scheme and Stornoway will pay the Cash Consideration payable to the holders of Cancellation Shares pursuant to the Acquisition to former Calyx Shareholders. In addition, if the Scheme becomes effective, redeemable preference shares will be issued by Clayfox Timid, and ordinary shares will be issued by Clayfox Gilttop, to Maurice Healy, in consideration for the transfer of the Exchange Shares to Clayfox Timid and Clayfox Gilttop. Exchange Shares issued pursuant to the exercise of Calyx Share Options will be transferred to Stornoway in exchange for cash. As a result of these arrangements, all of Calyx's issued share capital will be owned by Stornoway, Clayfox Timid and Clayfox Gilttop after the Scheme becomes effective. To become effective, the Scheme requires, amongst other things, the approval at the Court Meetings of a majority in number of Calyx Shareholders, present and voting either in person or by proxy, representing three-fourths (75 per cent.) or more in value of the Calyx Shares held by such holders, as well as the approval by Calyx Shareholders of resolutions relating to the implementation of the Scheme at an EGM to be held directly after the Court Meetings. There will be two Court Meetings: the Stornoway Class Shareholders will vote at the second, and all other Calyx Shareholders will vote at the first. A separate Court Meeting is required for the Stornoway Class Shareholders because their interest in the outcome of the Scheme differs from that of other Calyx Shareholders. The Stornoway Class Shareholders comprise the members of the Management Team who are Calyx Shareholders and Anglo Irish Bank Corporation plc (debt provider to the Stornoway Group as described in paragraph 7 of this announcement) in respect of the Calyx Shares it holds as principal. Assuming the necessary approvals from the Calyx Shareholders have been obtained and all conditions have been satisfied or (where applicable) waived, the Scheme will become effective upon delivery to the Registrar of Companies of a copy of the Court Order of the High Court sanctioning the Scheme together with the minute required by Section 75 of the Companies Act and registration of such order by him. The Acquisition is conditional on the Scheme becoming effective. The conditions to the Acquisition and the Scheme are set out in full in Appendix I of this announcement. The implementation of the Scheme is conditional, amongst other things, upon: • the Scheme becoming effective by not later than 30 September 2007 or such later date as Stornoway and Calyx may, with the consent of the Panel, agree and the High Court may allow, failing which the Scheme will lapse; • the approval of the Scheme, by a majority in number representing three-fourths or more in value of the holders of Calyx Shares present and voting either in person or by proxy, at the Court Meetings (or at any adjournment of such meeting); • the passing of such resolutions in connection with and/or as are required to approve or implement the Scheme at the Extraordinary General Meeting; • the sanction of the Scheme and confirmation of the reduction of capital involved therein by the High Court and the delivery of an office copy of the Court Order and the minute required by Section 75 of the Companies Act to the Registrar of Companies and the registration of such Court Order by him; and • the conditions that are not otherwise identified above being satisfied or waived on or before the sanction of the Scheme by the High Court pursuant to Section 201 of the Companies Act. The Scheme Document, containing further information relating to the implementation of the Scheme, the full terms and conditions of the Scheme, and the notices of the Court Meetings to be convened by direction of the High Court and the separate Extraordinary General Meeting required to approve the Scheme, will be posted as soon as reasonably practicable, and in any event within 28 days of the date of this announcement, to Calyx Shareholders and, for information only, to Calyx Optionholders. The Scheme Document will also include details of the expected timetable for implementation of the Scheme and will specify the actions to be taken by Calyx Shareholders. It is expected that the Acquisition and Scheme will become effective during the course of July 2007. Upon the Scheme becoming effective, it will be binding on all Calyx Shareholders, irrespective of whether or not they attended or voted at the Court Meetings or the EGM. 16. Cancellation of admission to AIM and the IEX It is intended that, prior to and subject to the Scheme becoming effective, and subject to any applicable requirements of the Irish Stock Exchange and the London Stock Exchange, Stornoway will procure that Calyx applies for cancellation of the admission to trading of Ordinary Shares on the markets of IEX and AIM with effect from the Effective Date. The last day of dealing in Ordinary Shares on IEX and AIM will be the last Business Day before the Effective Date. On the Effective Date, share certificates in respect of the Calyx Shares will cease to be valid and should be destroyed. In addition, entitlements to Calyx Shares held within the CREST system will be cancelled on the Effective Date. It is also proposed that, following the Effective Date and after the Calyx Shares are delisted, Calyx will be re-registered as a private limited company. 17. General Stornoway reserves the right to elect to implement the acquisition of the Shares by way of a takeover offer. In such event, the takeover offer will be implemented on terms which are in all material respects at least as favourable to Calyx Shareholders as those which would otherwise have applied under the Scheme (subject to appropriate amendments). The Acquisition and Scheme will be made subject to the conditions and further terms set out in Appendix I and to be set out in the Scheme Document. The Scheme Document will include full details of the Acquisition and Scheme and the expected timetable and will be accompanied by the appropriate forms of proxy. These will be despatched to Calyx Shareholders and, for information only, to Calyx Optionholders, in due course. The Acquisition and Scheme will be governed by the laws of Ireland and will be subject to the applicable requirements of the Takeover Rules, the Irish Stock Exchange, the London Stock Exchange, and applicable laws. The bases and sources of certain financial information contained in this announcement are set out in Appendix 2. Certain terms used in this announcement are defined in Appendix 3. This announcement is being made pursuant to Rule 2.5 of the Takeover Rules. Enquiries: Deloitte Corporate Finance +44 (0) 20 7936 3000 Financial Adviser to Stornoway Limited Jonathan Hinton David Smith Buchanan Communications +44 (0) 20 7466 5000 Public Relations adviser to Stornoway Limited Tim Thompson James Strong Calyx Group plc +353 (0) 1 883 5555 Gary Kennedy Davy Corporate Finance +353 (0) 1 679 6363 Financial Adviser to Calyx Group plc Ronan Godfrey John Frain Murray Consultants +353 (0) 1 498 0300 Public Relations adviser to Calyx Group plc Ed Micheau The directors of Stornoway, Stornoway I, Clayfox Timid and Clayfox Gilttop, acting in their capacity as such, the directors of Alchemy Partners (Guernsey), and the Management Team (together the 'Responsible Parties'), accept responsibility for the information contained in this announcement relating to Stornoway, Stornoway I, Clayfox Timid, Clayfox Gilttop, the directors of Alchemy Partners (Guernsey) and the Management Team, and members of their immediate families, related trusts and persons connected with them. To the best of the knowledge and belief of the Responsible Parties (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. The Calyx Directors accept responsibility for all the information contained in this announcement, other than information relating to Stornoway, Stornoway I, Clayfox Timid, Clayfox Gilttop, the Management Team or the directors of Alchemy Partners (Guernsey) and members of their immediate families, related trusts and persons connected with them, and the recommendation of the Acquisition and the Scheme by the Independent Directors and associated opinions. To the best of the knowledge and belief of the Calyx Directors (who have taken all reasonable care to ensure that such is the case), the information in this announcement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. The Independent Directors accept responsibility for their recommendation of the Acquisition and the Scheme and associated opinions contained in this announcement. To the best of the knowledge and belief of the Independent Directors (who have taken all reasonable care to ensure that such is the case), the information for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. This announcement is not intended to and does not constitute an offer to sell or subscribe for or invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise. Any response in relation to the Acquisition should be made only on the basis of the information in the Scheme Document or any document by which the Acquisition and Scheme are made. Calyx and Stornoway urge Calyx Shareholders to read the Scheme Document when it becomes available because it will contain important information relating to the Acquisition. Davy Corporate Finance, which is authorised in Ireland by the Financial Regulator under the Investment Intermediaries Act 1995, is acting exclusively for Calyx and no-one else in connection with the Acquisition and will not be responsible to anyone other than Calyx for providing the protections afforded to clients of Davy Corporate Finance or for providing advice in relation to the Acquisition. Deloitte Corporate Finance is acting exclusively for Stornoway and no one else in connection with the Acquisition and will not regard any other person as its client nor be responsible to anyone other than Stornoway for providing the protections afforded to clients of Deloitte Corporate Finance nor for providing advice in relation to the Offer, or any matter referred to in this announcement. Deloitte Corporate Finance is a division of Deloitte & Touche LLP, which is authorised and regulated by the Financial Services Authority in respect of regulated activities. The distribution of this announcement in or into certain jurisdictions may be restricted by the laws of those jurisdictions. Accordingly, copies of this announcement and all other documents relating to the Acquisition are not being, and must not be, mailed or otherwise forwarded, distributed or sent in, into or from any Restricted Jurisdiction. Persons receiving such documents (including, without limitation, nominees, trustees and custodians) should observe these restrictions. Failure to do so may constitute a violation of the securities laws of any such jurisdiction. This announcement, including information included or incorporated by reference in this announcement, may contain 'forward-looking statements' concerning the Acquisition, Calyx, Stornoway, Stornoway I, Clayfox Timid and Clayfox Gilttop. Generally, the words 'will', 'may', 'should', 'could', 'would', 'can', 'continue', 'opportunity', 'believes', 'expects', 'intends', 'anticipates', 'estimates' or similar expressions identify forward-looking statements. The forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond the companies' abilities to control or estimate precisely, such a future market conditions and the behaviours of other market participants, and therefore undue reliance should not be placed on such statements. Neither Calyx, Stornoway, Stornoway I, Clayfox Timid nor Clayfox Gilttop assume any obligation in respect of, or intend to update these forward-looking statements, except as required pursuant to applicable law. Any person who is a holder of one per cent. or more of the Calyx Shares may have disclosure obligations under Rule 8.3 of the Takeover Rules, effective from the date of the commencement of the offer period in respect of the Acquisition. APPENDIX 1 CONDITIONS AND CERTAIN FURTHER TERMS OF THE ACQUISITION AND SCHEME The Acquisition and Scheme comply with the Takeover Rules and, where relevant, the IEX Rules and AIM Rules and are subject to the terms and conditions set out in this document. The Acquisition and Scheme are governed by laws of Ireland and subject to the exclusive jurisdiction of the courts of Ireland, which exclusivity shall not limit the right to seek provisional or protective relief in the courts of another State during or after any substantive proceedings have been instituted in Ireland, nor shall it limit the right to bring enforcement proceedings in another State on foot of an Irish judgment. 1. The Acquisition will be conditional upon the Scheme becoming effective and unconditional by not later than 30 September 2007 (or such lesser period as may be required by the Panel, or such later date as Stornoway and Calyx may, with the consent of the Panel, agree and the Court may allow). The Scheme will be conditional upon: (i) the approval of the Scheme by a majority in number representing three-fourths or more in value of the holders of Calyx Shares at the Voting Record Time, present and voting either in person or by proxy, at the Court Meetings (or at any adjournment of such meetings); (ii) such resolution(s) in connection with and/or required to approve or implement the Scheme and set out in the notice convening the Extraordinary General Meeting being duly passed by the requisite majority at the Extraordinary General Meeting (or at any adjournment of such meeting) including, for the avoidance of doubt, the Rule 16 Resolution; and (iii) the sanction (with or without modification) of the Scheme and the confirmation of the reduction of capital involved therein by the Court and office copies of the Court Orders and the minute required by section 75 of the Companies Act in respect of the reduction, being delivered for registration to the Registrar of Companies and registration of the Court Order and minute confirming the reduction of capital involved in the Scheme by the Registrar of Companies. 2. Calyx and Stornoway have agreed that, subject to paragraph 3 of this Appendix I, the Acquisition will also be conditional upon the following matters having been satisfied or waived on or before the sanction of the Scheme by the High Court pursuant to Section 201 of the Companies Act: (a) To the extent that Part 3 of the Competition Act 2002 (the ' Act') is applicable to the Acquisition: (i) the Competition Authority referred to in Section 29 of the Act (the 'Authority') having, in accordance with Section 21(2)(a) of the Act, informed Calyx and Stornoway that the Acquisition may be put into effect; or (ii) the period specified in Section 21(2) (as may be extended under Section 21(4) of the Act), of the Act having elapsed without the Authority having informed Calyx and Stornoway of the determination (if any) which it has made under Section 21(2) of the Act; or (iii) the Authority, having informed Calyx and Stornoway that it has been determined under Section 22(3)(a) of the Act that the Acquisition my be put into effect; or (iv) the Authority, having informed Calyx and Stornoway that it has determined under Section 22(3)(c) of the Act that the Acquisition may be put into effect subject to conditions specified by the Authority being complied with and such conditions not being, in the reasonable opinion of Stornoway, of a material nature in the context of the Acquisition or the business of Calyx; or (v) the period of four months after the appropriate date (as defined in Section 19(6) of the Ac) having elapsed without the Authority having made a determination under Section 22(3) of the Act in relation to the Acquisition. (b) no central bank, government or governmental, quasi-governmental, supranational, statutory, regulatory or investigative body, including any national anti-trust or merger control authorities, court, tribunal, trade agency, professional association, environmental body, any analogous body whatsoever or tribunal in any jurisdiction (each a 'Third Party') having decided to take, institute or implement any action, proceeding, suit, investigation, enquiry or reference or having made, proposed or enacted any statute, regulation or order or having withheld any consent or having done or decided to do anything which would or might reasonably be expected to: (i) make the Acquisition or its implementation, or the acquisition or the proposed acquisition by Stornoway of any shares in, or control of, Calyx, or any of the material assets of Calyx void, illegal or unenforceable under the laws of any jurisdiction, or otherwise, directly or indirectly, restrain, revoke, prohibit, materially restrict or materially delay the same or impose additional or different conditions or obligations with respect thereto (except for conditions or obligations that would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole) or otherwise challenge or interfere therewith (except where the result of such challenge or interference would not have, or would not reasonably be expected to have, a material adverse effect on the Wider Calyx Group taken as a whole); (ii) result in a material delay in the ability of Stornoway, or render Stornoway unable, to acquire some or all of the Calyx Shares or require a divestiture by any member of the Wider Stornoway Group of any shares in Calyx; (iii) (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole) require, prevent or delay the divestiture by any member of the Stornoway Group or by any member of the Wider Calyx Group of all or any portion of their respective businesses, assets (including, without limitation, the shares or securities of any other member of the Calyx Group) or property or (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole) impose any limitation on the ability of any of them to conduct their respective businesses (or any of them) or own their respective assets or properties or any part thereof; (iv) impose any material limitation on or result in a material delay in the ability of Stornoway to acquire, or to hold or to exercise effectively, directly or indirectly, all or any rights of ownership of shares (or the equivalent) in, or to exercise voting or management control over, Calyx or any member of the Wider Calyx Group which is material in the context of the Wider Calyx Group taken as a whole or (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole) on the ability of any member of the Wider Calyx Group to hold or exercise effectively, directly or indirectly, rights of ownership of shares (or the equivalent) in, or to exercise rights of voting or management control over, any member of the Wider Calyx Group which is material in the context of the Wider Calyx Group taken as a whole; (v) (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group, taken as a whole) require any member of the Wider Stornoway Group or any member of the Wider Calyx Group to acquire or offer to acquire any shares or other securities (or the equivalent) in, or any interest in any asset owned by, any member of the Wider Calyx Group owned by any third party; (vi) impose any limitation on the ability of any member of the Calyx Group to integrate or co-ordinate its business, or any part of it, with the businesses of any member of the Wider Calyx Group (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole); (vii) result in any member of the Wider Calyx Group ceasing to be able to carry on business in any jurisdiction in which it presently does so (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole); (viii) cause any member of the Wider Calyx Group to cease to be entitled to any Authorisation (as defined in paragraph (c) below) used by it in the carrying on of its business (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group, taken as a whole); or (ix) otherwise materially adversely affect the business, profits, assets, liabilities, financial or trading position of any member of the Wider Calyx Group (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole); (c) all necessary notifications and filings having been made, all necessary waiting and other time periods (including any extensions thereof) under any applicable legislation or regulation of any jurisdiction in which Calyx or any subsidiary or subsidiary undertaking of Calyx having expired, lapsed or having been terminated (as appropriate) (save to an extent which would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole) and all statutory or regulatory obligations in any jurisdiction in which Calyx or a subsidiary shall be incorporated or carry on business which is material in the context of the Wider Calyx Group taken as a whole having been complied with (save to an extent which would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole), in each case, in connection with the Acquisition or its implementation and all authorisations, orders, recognitions, grants, consents, clearances, confirmations, licences, permissions and approvals in any jurisdiction (' Authorisations' and each an 'Authorisation') reasonably deemed necessary by Stornoway for or in respect of the Acquisition having been obtained on terms and in a form reasonably satisfactory to Stornoway from all appropriate Third Parties, (except where the consequence of the absence of any such Authorisation would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole) all such Authorisations remaining in full force and effect, there being no written notice of an intention to revoke or vary or not to renew the same at the time at which the Acquisition becomes otherwise unconditional and all necessary statutory or regulatory obligations in any such jurisdiction having been complied with (except where the consequence of the absence of any such Authorisation would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole); (d) all applicable waiting periods and any other time periods during which any Third Party could, in respect of the Acquisition or the acquisition or proposed acquisition of any shares or other securities (or the equivalent) in, or control of, Calyx or any member of the Wider Calyx Group by Stornoway, institute or implement any action, proceedings, suit, investigation, enquiry or reference under the laws of any jurisdiction which would be reasonably expected adversely to affect (to an extent which would be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole) any member of the Calyx Group, having expired, lapsed or been terminated; (e) except as disclosed, there being no provision of any arrangement, agreement, licence, permit, franchise, facility, lease or other instrument to which any member of the Wider Calyx Group is a party or by or to which any such member or any of its respective assets may be bound, entitled or be subject and which, in consequence of the Acquisition or the acquisition or proposed acquisition by Stornoway of any shares or other securities (or the equivalent) in or control of, Calyx or any member of the Calyx Group or because of a change in the control or management of Calyx or otherwise, would or would be reasonably expected to result (except where, in any of the following cases, the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as whole) in: (i) any monies borrowed by, or any indebtedness or liability (actual or contingent) of, or any grant available to any member of the Wider Calyx Group becoming, or becoming capable of being declared, repayable immediately or prior to their or its stated maturity; (ii) the creation or enforcement of any mortgage, charge or other security interest wherever existing or having arisen over the whole or any part of the business, property or assets of any member of the Wider Calyx Group or any such mortgage, charge or other security interest becoming enforceable; (iii) any such arrangement, agreement, licence, permit, franchise, facility, lease or other instrument or the rights, liabilities, obligations or interests of any member of the Wider Calyx Group thereunder, or the business of any such member with, any person, firm or body (or any arrangement or arrangements relating to any such interest or business) being terminated or adversely modified or any adverse action being taken or any obligation or liability arising thereunder; (iv) any assets or interests of, or any asset the use of which is enjoyed by, any member of the Wider Calyx Group being or falling to be disposed of or charged, or ceasing to be available to any member of the Wider Calyx Group or any right arising under which any such asset or interest would be required to be disposed of or charged or would cease to be available to any member of the Wider Calyx Group otherwise than in the ordinary course of business; (v) any member of the Wider Calyx Group ceasing to be able to carry on business; (vi) the value of, or financial or trading position of any subsidiary being prejudiced or adversely affected; or (vii) the creation of any liability or liabilities (actual or contingent) by any member of the Wider Calyx Group; unless, if any such provision exists, such provision shall have been waived, modified or amended on terms satisfactory to Stornoway; (f) except as disclosed and/or save as publicly announced (by the delivery of an announcement to the Irish Stock Exchange or the London Stock Exchange or otherwise publicly disclosed in the Calyx Group's preliminary results announcement for the year ended 31 December 2006) by Calyx, no member of the Wider Calyx Group having, since 31 December 2006: (i) issued or agreed to issue additional shares of any class, or securities convertible into or exchangeable for, or rights, warrants or options to subscribe for or acquire, any such shares or convertible or exchangeable securities (except for (A) issues to Calyx or wholly-owned subsidiaries of Calyx, or (B) upon any exercise of options under the Calyx Share Option Schemes); (ii) recommended, declared, paid or made any bonus, dividend or other distribution other than bonuses, dividends or other distributions lawfully paid or made to another member of the Wider Calyx Group; (iii) save for transactions between two or more members of the Calyx Group ('intra-Calyx Group transactions') made or authorised, proposed or announced any change in its loan capital (save in respect of loan capital which is not material (in value terms or otherwise) in the context of the Calyx Group taken as a whole); (iv) save for intra-Calyx Group transactions, implemented, authorised, proposed or announced its intention to propose any merger, demerger, reconstruction, amalgamation, scheme or (except in the ordinary and usual course of trading) acquisition or disposal of (or of any interest in) assets or shares (or the equivalent thereof) in any undertaking or undertakings (except in any such case where the consequences of any such merger, demerger, reconstruction, amalgamation, scheme, acquisition or disposal would not be material (in value terms or otherwise) in the context of the Calyx Group taken as a whole); (v) except in the ordinary and usual course of business entered into or materially improved, or made any offer (which remains open for acceptance) to enter into or improve, the terms of the employment contract with any director of Calyx or any person occupying one of the senior executive positions in the Calyx Group; (vi) permitted a variation in the terms or rules governing the Calyx Share Option Schemes; (vii) (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Calyx Group, taken as a whole) issued or agreed to issue any loan capital or (save in the ordinary course of business and save for intra-Calyx Group transactions) debentures or incurred any indebtedness or contingent liability; (viii) purchased, redeemed or repaid or announced any offer to purchase, redeem or repay any of its own shares or other securities (or the equivalent) or reduced or made any other change to any part of its share capital; (ix) (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole) (A) merged with any body corporate, partnership or business, or (B) and save for intra-Calyx Group transactions acquired or disposed of, transferred, mortgaged or encumbered any assets or any right, title or interest in any asset (including shares and trade investments); (x) (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole), entered into or varied any contract, transaction, arrangement or commitment or announced its intention to enter into or vary any contract, transaction, arrangement or commitment (whether in respect of capital expenditure or otherwise) which is of a long term, onerous or unusual nature or magnitude or which is or would be restrictive on the business of any member of the Wider Calyx Group; (xi) waived or compromised any claim which would be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole; (xii) (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group, taken as a whole) been unable, or admitted in writing that it is unable, to pay its debts or having stopped or suspended (or threatened to stop or suspend) payment of its debts generally or ceased or threatened to cease to carry on all or a substantial part of any business; (xiii) (except where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole) made or agreed to any significant change to the terms of the trust deeds constituting the pension schemes established for its directors and/or employees and/or their dependants or to the benefits which accrue, or to the pensions which are payable thereunder, or to the basis on which qualification for or accrual or entitlement to such benefits or pensions are calculated or determined, or to the basis upon which the liabilities (including pensions) of such pension schemes are funded or made, or agreed or consented to any change to the trustees involving the appointment of a trust corporation; (xiv) take any corporate action or had any legal proceedings instituted against it in respect of its winding-up, dissolution, examination or reorganisation or for the appointment of a receiver, examiner, administrator, administrative receiver, trustee or similar officer of all or any part of its assets or revenues, or (A) any analogous proceedings in any jurisdiction, or (B) appointed any analogous person in any jurisdiction in which Calyx or any subsidiary shall be incorporated or carry on any business; (xv) entered into any agreement, contract or binding commitment or passed any resolution or made any offer or announcement with respect to, or to effect any of the transactions, matters or events set out in this condition; or (xvi) amended its memorandum or articles of association; (g) except as disclosed and/or save as publicly announced by Calyx (by delivery of an announcement to the Irish Stock Exchange or the London Stock Exchange or otherwise publicly disclosed in the Calyx Group's preliminary results announcement for the year ended 31 December 2006) on or prior to the issue of this announcement: (i) there not having arisen any adverse change or deterioration in the business, assets, financial or trading position or profits of Calyx or any member of the Wider Calyx Group (save to an extent which would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole); (ii) no litigation, arbitration proceedings, prosecution or other legal proceedings to which any member of the Wider Calyx Group is or would reasonably be expected to become a party (whether as plaintiff or defendant or otherwise) and no investigation by any Third Party against or in respect of any member of the Wider Calyx Group having been instituted or remaining outstanding by, against or in respect of any member of the Calyx Group (save where the consequences of such litigation, arbitration proceedings, prosecution or other legal proceedings or investigation are not or would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole); (iii) no contingent or other liability existing or having arisen which would reasonably be expected to affect adversely any member of the Wider Calyx Group (save where such liability is not or would not be material (in value terms) in the context of the Wider Calyx Group taken as a whole); and (iv) no steps having been taken which are likely to result in the withdrawal, cancellation, termination or modification of any licence, consent, permit, Access Right or authorisation held by any member of the Wider Calyx Group which is necessary for the proper carrying on of its business and which is material in the context of the Wider Calyx Group; (h) except as disclosed, Stornoway not having discovered that any financial, business or other information concerning the Wider Calyx Group which is material in the context of the Wider Calyx Group taken as a whole and which has been publicly disclosed, is materially misleading, contains a material misrepresentation of fact or omits to state a fact necessary to make the material information contained therein not misleading (save where the consequences thereof would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as a whole); (i) except as disclosed and/or save as publicly announced (by delivery of an announcement to the Irish Stock Exchange or the London Stock Exchange or otherwise publicly disclosed in the Calyx Group's preliminary results announcement for the year ended 31 December 2006) by Calyx on or prior to the issue of this announcement, Stornoway not having discovered: (i) that any member of the Wider Calyx Group or any partnership, company or other entity in which any member of the Wider Calyx Group has an interest and which is not a subsidiary undertaking of Calyx is subject to any liability, contingent or otherwise (save where such liability is not or would not be material (in value terms or otherwise) in the context of the Wider Calyx Group taken as whole); (ii) in relation to any release, emission, discharge, disposal or other fact or circumstance which has caused or reasonably might impair the environment or harm human health, that any past or present member of the Wider Calyx Group has acted in violation of any laws, statutes, regulations, notices or other legal or regulatory requirements of any Third Party. (iii) that there is, or is likely to be, any liability, whether actual or contingent, to make good, repair, reinstate or clean up any property now or previously owned, occupied or made use of by any past or present member of the Wider Calyx Group or any other property or any controlled waters under any environmental legislation, regulation, notice, circular, order or other lawful requirement of any relevant Authority (whether by formal notice or order or not) or Third Party or otherwise (save where such liability is not or would not be material (in value terms or otherwise) in the context of the Calyx Group taken as a whole); and (iv) that circumstances exist at the date the offer is made which are likely to result in any actual or contingent liability to any member of the Wider Calyx Group under any applicable legislation referred to in sub-paragraph (iii) above to improve or modify existing or install new plant, machinery or equipment or to carry out any changes in the processes currently carried out (except where the cost of doing so would not be material (in value terms or otherwise) in the context of the Wider Calyx Group, taken as a whole). (j) except as disclosed, no member of the Calyx Group being in default under the terms or conditions of any facility or agreement or arrangement for the provision of loans, credit or drawdown facilities, or of any security, surety or guarantee in respect of any facility or agreement or arrangement for the provision of loans, credit or drawdown facilities to any member of the Calyx Group;. (k) for the purposes of the conditions set out above: (i) 'Calyx Group' means Calyx and its subsidiaries and subsidiary undertakings; (ii) 'disclosed' means fairly and accurately disclosed by or on behalf of Calyx in writing (or in written form), to Stornoway or Deloitte or its respective employees, officers or advisers at any time up to 25 May 2007 (being the date of this announcement) or orally at formal due diligence meetings between representatives of Stornoway and Calyx; (iii) 'parent undertaking', 'subsidiary undertaking', 'associated undertaking' and 'undertaking' have the meanings given by the European Communities (Companies: Group Accounts) Regulations, 1992; (iv) 'substantial interest' means an interest in 20 per cent or more of the voting equity capital of an undertaking; (v) 'Wider Calyx Group' means Calyx or any of its subsidiaries or subsidiary undertakings or associated companies (including any joint venture, partnership, firm or company or undertaking in which any member of the Stornoway Group (aggregating their interests) is interested) or any company in which any such member has a substantial interest; and (vi) 'Wider Stornoway Group' means Stornoway or any of its subsidiaries or subsidiary undertakings or associated companies (including any joint venture, partnership, firm or company or undertaking in which any member of the Stornoway Group (aggregating their interests) is interested) or any company in which any such member has a substantial interest. 3. Subject to the requirements of the Panel, Stornoway reserves the right (but shall be under no obligation) to waive, in whole or in part, all or any of the above conditions apart from conditions 1(i), (ii) and (iii) and 2(a). 4. The Acquisition will lapse unless all of the conditions set out above have been fulfilled or (if capable of waiver) waived or, where appropriate, have been determined by Stornoway to be or to remain satisfied on the Effective Date. 5. If Stornoway is required to make an offer for Calyx Shares under the provisions of Rule 9 of the Takeover Rules, Stornoway may make such alterations to any of the above conditions as are necessary to comply with the provisions of that rule. 6. Stornoway reserves the right to effect the Acquisition by way of a takeover offer. In such event, such offer will be implemented on the same terms (subject to appropriate amendments, including (without limitation) an acceptance condition set at 80 per cent. of the Calyx Shares affected other than Calyx Shares already in the beneficial ownership of Stornoway within the meaning of Section 204 of the Companies Act (but capable of waiver on a basis consistent with Rule 10 of the Takeover Rules)), so far as applicable, as those which would apply to the Scheme. APPENDIX 2 BASES AND SOURCES 1. The value attributed to the existing issued share capital of Calyx is based upon the 69,526,914 Shares in issue as at the Latest Practicable Date. 2. Unless otherwise stated, the financial information on Calyx is extracted from Calyx's preliminary results announcement for the year ended 31 December 2006 and annual report and accounts for the year ended 31 December 2005. 3. Unless otherwise stated, all prices for Calyx Shares have been derived from the Daily Official List of the Irish Stock Exchange or the London Stock Exchange (as the case may be) and represent Closing Prices on the relevant date. 4. The maximum cash consideration due pursuant to the Acquisition referred to in paragraph 9 of this announcement is based upon the 55,996,221 Cancellation Shares in issue as at the Latest Practicable Date and 4,252,600 Calyx Shares which are capable of being issued under the Calyx Share Option Schemes. 5. 2,416,900 Calyx Shares are capable of being issued under the 2005 Employee Share Option Plan and 1,835,700 Calyx Shares are capable of being issued under the EMI Sub-Plan for UK employees of Calyx. 6. The value attributed to the senior debt and mezzanine finance to be provided by Anglo Irish Bank Corporation plc is based upon an exchange rate of 1.47830 euros to £1, being the prevailing mid-point exchange rate as at 5 p.m. London time on the Latest Practicable Date. APPENDIX 3 DEFINITIONS The following definitions apply throughout this announcement, unless the context otherwise requires: 'Acquisition' the proposed acquisition by Stornoway of the entire issued and to be issued share capital of Calyx by means of the Scheme; 'AIM' the Alternative Investment Market operated by the London Stock Exchange. 'AIM Rules' the rules for companies with a class of securities admitted to AIM and their nominated advisers published by the London Stock Exchange governing admission to and the operation of AIM as in force at the date of this announcement; 'Alchemy Investment Plan' the discretionary funds managed by Alchemy Partners (Guernsey) with advice from Alchemy Partners; 'Alchemy Partners' Alchemy Partners LLP, the limited liability partnership which provides investment advice to the Alchemy Investment Plan; 'Alchemy Partners (Guernsey)' Alchemy Partners (Guernsey) Limited, the manager of the Alchemy Investment Plan; 'Arrangement' any indemnity or option arrangement and any agreement or understanding, formal or informal, of whatever nature between two or more persons, relating to relevant securities of Calyx or Stornoway which is or may be an inducement to one or more such persons to deal or refrain from dealing in such securities; 'Australia' the Commonwealth of Australia, its states, territories and possessions; 'Board' as the context requires, the board of directors of Calyx or the board of directors of Stornoway and the terms 'Calyx Board' and 'Stornoway Board' shall be construed accordingly; 'Business Day' a day, other than a Saturday or Sunday, on which clearing banks are normally open for business in Dublin and London; 'Calyx Directors' the directors of Calyx, being Maurice Healy, Peter Jenkins, Gerard Coakley, Judith O'Brien, Gary Kennedy, Nicholas Koumarianos and Neil Parkinson; 'Calyx' or the 'Company' Calyx Group plc, a public limited company incorporated in Ireland; 'Calyx Group' or the 'Group' Calyx, its subsidiaries and its subsidiary undertakings; 'Calyx Optionholders' holders of Calyx Share Options; 'Calyx Shareholders' the holders of Calyx Shares; 'Calyx Share Options' options to subscribe for Ordinary Shares pursuant to the Calyx Share Option Schemes; 'Calyx Share Option Schemes' the Calyx 2005 Employee Share Option Plan and the EMI Sub-Plan for UK employees of Calyx; 'Calyx Shares' or 'Ordinary Shares' the existing unconditionally allotted or issued and fully paid ordinary shares of €0.10 each in Calyx and such further shares which are allotted or issued prior to the Effective Date; 'Canada' Canada, its provinces, territories and all areas subject to its jurisdiction and any political sub-division thereof; 'Cancellation Shares' Calyx Shares, other than the Exchange Shares and Designated Shares; 'Cash Consideration' 101 pence per Calyx Share; 'Clayfox Gilttop' Clayfox Gilttop Limited, a private limited company incorporated in England and Wales with registration number 06242133; 'Clayfox Timid' Clayfox Timid Limited, a private limited company incorporated in England and Wales with registration number 06242135; 'Closing Price' the official closing price or middle market quotation, as appropriate, of a Calyx Share as derived from the Daily Official List; 'Companies Act' the Companies Act 1963 of Ireland; 'Competing Cash Offer' an offer or scheme of arrangement for the acquisition of the entire issued and to be issued share capital of Calyx which (i) is wholly in cash, payable on completion, at a price per Calyx Share of at least 10 per cent. more than 101 pence, (ii) is recommended by the Independent Directors, and (iii) is announced within one month of the date of this announcement; 'Court Meetings' the meetings of Calyx Shareholders (and any adjournment thereof) convened by order of the High Court pursuant to Section 201 of the Companies Act to consider, and if thought fit, approve the Scheme (with or without amendment); 'Court Order' the order or orders of the High Court sanctioning the Scheme under Section 201 of the Companies Act and confirming the reduction of share capital which forms part of it under Sections 72 and 74 of the Companies Act; 'CREST' the relevant system (as defined in the Regulations) in respect of which CRESTCo is the operator (as defined in the Regulations); 'CRESTCo' CRESTCo Limited; 'Daily Official List' the daily official list of the Irish Stock Exchange and the London Stock Exchange as the case may be; 'Davy Corporate Finance' Davy Corporate Finance Limited; 'Deloitte Corporate Finance' Deloitte & Touche LLP acting through its corporate finance division; 'Designated Shares' one Calyx Share to be held by Stornoway, and six other Calyx Shares to be held by nominees for Stornoway; 'Effective Date' the date on which the Scheme becomes effective in accordance with its terms; 'EGM' or 'Extraordinary General Meeting' the extraordinary general meeting of the Calyx Shareholders (and any adjournment thereof) to be convened in connection with the Scheme, expected to be held as soon as the preceding Court Meetings shall be concluded or adjourned; 'euro' or '€' the lawful currency for the time being of Ireland; 'Exchange Shares' 13,530,693 Calyx Shares beneficially owned by Maurice Healy and any Calyx Shares that are issued after the High Court gives the Court Order but before the Scheme becomes effective in accordance with its terms; 'Expenses Reimbursement Agreement' the agreement described in paragraph 12 hereof; 'Financial Regulator' the Irish Financial Services Regulatory Authority 'High Court' the High Court of Ireland; 'IEX' the Irish Enterprise Exchange operated by the Irish Stock Exchange; 'IEX Rules' the rules for companies with a class of securities admitted to IEX published by the Irish Stock Exchange governing admission to and the operation of IEX as in force at the date of this announcement; 'Implementation Agreement' the implementation agreement between Calyx and Stornoway in relation to the implementation of the Scheme; 'Independent Directors' Gary Kennedy, Nicholas Koumarianos and Neil Parkinson; 'Independent Shareholders' Calyx Shareholders excluding the Management Team and members of their respective families; 'Ireland' Ireland (excluding Northern Ireland) and the word 'Irish' shall be construed accordingly; 'Irish Stock Exchange' The Irish Stock Exchange Limited; 'Irish Takeover Act' Irish Takeover Panel Act 1997; 'Latest Practicable Date' 24 May 2007; 'London Stock Exchange' London Stock Exchange plc; 'Management Arrangements' the proposed arrangements described in paragraph 10 hereof; 'Management Team' Maurice Healy, Peter Jenkins, Gerard Coakley, Andrew Mills and Jack Cunnane; 'Matrix Companies' MXC Integration Limited, Network Partners Limited, Network Partners (Holdings) Limited, Ikan Limited, HarrierZeuros Limited and Norwood Adam Systems Limited; 'Northern Ireland' the counties of Antrim, Armagh, Derry, Down, Fermanagh and Tyrone on the island of Ireland; 'Offer Period' the offer period for the purposes of the Takeover Rules which commenced on 13 March 2007, being the date of the announcement by Calyx that it had received an approach which may or may not lead to an offer being made for the Company, and ending on the earlier of the date on which the Scheme becomes effective and the date on which the Scheme lapses or is withdrawn; 'Overseas Shareholders' Calyx Shareholders who are citizens or residents of jurisdictions outside of the UK and Ireland; 'Panel' the Irish Takeover Panel established under the Irish Takeover Act; 'Regulations' the Companies Act 1990 (Uncertified Securities) Regulations 1996 (SI No. 68 of 1996); 'relevant securities' has the meaning assigned by Rule 8.9 of the Takeover Rules; 'Restricted Jurisdiction' any jurisdiction in respect of which it would be unlawful for this announcement to be released, published or distributed, in whole or in part, in, into or from, including for the avoidance of doubt, Australia, Canada, Japan, South Africa or the United States; 'Rule 16 Resolution' the resolution to be proposed at the EGM, on which only the Independent Shareholders will be entitled to vote, to approve the Management Arrangements pursuant to Rule 16 of the Takeover Rules; 'Scheme' the proposed scheme of arrangement under Section 201 of the Companies Act and the capital reduction under Sections 72 and 74 of the Companies Act with or subject to any modifications, additions or conditions approved or imposed by the High Court and agreed by Stornoway and Calyx; 'Scheme Document' a circular for distribution to Calyx Shareholders and, for information only, to Calyx Optionholders containing (i) the Scheme (ii) the notice or notices of the Court Meetings and EGM (iii) an explanatory statement as required by Section 202 of the Companies Act with respect to the Scheme (iv) such other information as may be required or necessary pursuant to the Companies Act, the Takeover Rules or the AIM Rules or IEX Rules and (v) such other information as Calyx and Stornoway shall agree; 'Scheme Record Time' 6 p.m. on the last Business Day before the date on which the Scheme becomes effective; 'Shareholders' Agreement' the agreement dated 25 May 2007 and made between the Management Team, Alchemy Partners (Guernsey), Stornoway, Stornoway I, Clayfox Timid and Clayfox Gilttop; 'Stornoway' Stornoway Limited, a private limited company incorporated in Ireland with registration number 438396; 'Stornoway I' Stornoway I Limited, a private limited company incorporated in Ireland with registration number 440129; 'Stornoway Class Shareholders' members of the Management Team who are Calyx Shareholders and Anglo Irish Bank Corporation plc in respect of the Calyx Shares it holds as principal; 'Stornoway Directors' Martin Bolland, Maurice Healy and Gerard Coakley; 'Stornoway Group' Stornoway, Stornoway I, Clayfox Timid and Clayfox Gilttop; 'Takeover Rules' the Irish Takeover Panel Act, 1997, Takeover Rules 2001 to 2006 (where applicable) and Substantial Acquisition Rules 2001 and 2005; 'United Kingdom' or 'UK' the United Kingdom of Great Britain and Northern Ireland; 'United States' or 'US' the United States of America, its territories and possessions, any state of the United States of America and the District of Columbia and any other area, subject to its jurisdiction; and 'Voting Record Time' the time and date to be specified as the voting record time for the Court Meetings (or any adjournment thereof) in the Scheme Document. All amounts contained within this document referred to by '€' and 'c' refer to the euro and cent. All amounts contained within this document referred to by '£' and 'pence' refer to pounds Sterling and pence Sterling. Any references to 'subsidiary undertaking', 'associated undertaking' and 'undertaking' have the meanings given by the European Communities (Companies: Group Accounts) Regulations 1992. Any references to any provision of any legislation shall include any amendment, modification, re-enactment or extension thereof. Any reference to any legislation is to Irish legislation unless specified otherwise. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings